Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.22 +0.09 (+2.06%)
As of: Oct 2, 2026 · 10:44 AM EDT

Adial Pharmaceuticals (ADIL) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Adial Pharmaceuticals (ADIL) posted Net Equity Issued and Repurchased of $26.48 million for Q2 2026, up 760.9% from $3.08 million a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Adial Pharmaceuticals was $28.49 million, up 757.0% year-over-year; for FY2025, it was $4.81 million, up 19.7% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
  • In prior years, Adial Pharmaceuticals' Net Equity Issued and Repurchased was $4.02 million in FY2024 (+18.9%), $3.38 million in FY2023, $1,865 in FY2022 (-100.0%) and $11.75 million in FY2021 (+127.8%).
  • The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2019.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in four of the last five quarters, with growth averaging 273.5%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2026, with growth of 760.9%; the weakest was Q1 2025, with a decline of 98.7%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $315,284 (Q1 2026), $1.21 million (Q4 2025) and $477,829 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn - 26.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.48 Mn
Mar 31, 2026 315,284.00
Dec 31, 2025 1.21 Mn
Sep 30, 2025 477,829.00
Jun 30, 2025 3.08 Mn
Mar 31, 2025 50,648.00
Sep 30, 2024 197,221.00
Mar 31, 2024 3.82 Mn
Dec 31, 2023 2.63 Mn
Sep 30, 2023 140,330.00
Mar 31, 2023 609,613.00
Dec 31, 2022 -9.12 Mn
Mar 31, 2022 9.12 Mn
Dec 31, 2021 800,000.00
Sep 30, 2021 5.50 Mn
Jun 30, 2021 2.81 Mn
Mar 31, 2021 2.64 Mn
Sep 30, 2020 500,000.00
Dec 31, 2019 -7.14 Mn
Mar 31, 2019 8.20 Mn
API Access

Adial Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ADIL&period=max&api_key=YOUR_API_KEY